Biodegradable amiodarone patches placed on the heart to prevent atrial fibrillation after open-heart surgery
Official title: BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery
Run by Jilin Heart Hospital · NCT06722196 · Data updated 2026-11-12
This trial will try placing biodegradable patches soaked with amiodarone on the outside of the atria during open-heart surgery to see if it reduces new atrial fibrillation after elective cardiac operations.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Jilin Heart Hospital Academic / other |
| Locations | 1 site (Changchun, Jinlin) |
| Status | Recruiting |
| Started | February 15, 2025 |
| Main results expected | January 15, 2027 |
| Study ends | December 15, 2027 |
| Registry record updated | December 9, 2025 |
| Trial ID | NCT06722196 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults scheduled for elective full-sternotomy cardiac surgery (coronary, valve, or ascending aorta procedures) who do not have a prior history of atrial or ventricular arrhythmia and who do not have pacemakers/ICDs, thyroid dysfunction, HOCM, or emergency/reoperative indications.
✕Probably not a fit
Patients with prior atrial or ventricular arrhythmias, those undergoing reoperation or emergency surgery, and those with pacemakers/ICDs, thyroid dysfunction, or HOCM are unlikely to qualify and are not expected to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, controlled Phase 3 trial compares two oxidized regenerated cellulose patches soaked with amiodarone versus saline applied over the anterior left atrium and lateral right atrium at the end of elective full-sternotomy cardiac surgery. Eligible procedures include coronary artery bypass, aortic, mitral, tricuspid, and ascending aorta operations performed on- or off-pump, while patients with prior atrial or ventricular arrhythmias, reoperations, emergency indications, pacemakers/ICDs, thyroid dysfunction, or HOCM are excluded. The primary outcome is the incidence of postoperative atrial fibrillation (POAF), with blinded outcome assessment and standard postoperative monitoring. The intervention aims to deliver local antiarrhythmic therapy to the atrial surface with limited systemic exposure compared with systemic drug dosing.
Why it matters
Potential benefit: If successful, this approach could lower rates of postoperative atrial fibrillation, reducing complications and potentially shortening hospital stays.
How similar studies have gone: Smaller clinical and experimental studies of topical or epicardial amiodarone have shown mixed but often encouraging reductions in POAF, while large-scale phase 3 evidence for soaked biodegradable patches remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients who are candidates for elective cardiac surgery trough complete sternotomy with indications of coronary artery disease (both off-pump and on-pump), aortic valve disease, mitral valve disease, tricuspid valve disease, and ascending aorta disease, whether as an isolated pathology or in combination Exclusion Criteria: * patients with a clinical history of atrial or ventricular arrhythmia of any nature and duration, patients undergoing reoperation, patients with emergency surgical indications due to acute myocardial infarction or cardiogenic shock, patients with thyroid disfunction, patients with HOCM and those with pacemakers or ICDs
Where it's running
-
Jilin Heart Hospital
Changchun, Jinlin, China Recruiting
Study contacts
- Principal investigator: Massimo G Lemma, PhD — Jilin Heart Hospital
- Study coordinator: Xin Lu
- Email: xin.lu@jlheart.org
- Phone: +86 13630550809
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.